(The Center Square) – The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans…
From
To
WEDNESDAY, June 18, 2025 (HealthDay News) -- On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited r…
TUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for…
Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, cut its annual sales forecast…
